1-5 of 5
Mark Thornquist
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Specific Drug Transporter Genotypes Are Significantly Associated with Increased Rates of Major and Complete Molecular Responses In Newly Diagnosed Chronic Myeloid Leukemia Patients Treated with Imatinib – A TOPS Correlative Substudy

Simona Soverini, Sabrina Angelini, Eleonora Turrini, Matt Burnett, Gloria Ravegnini, Mark Thornquist, Fabrizio Pane, MD, Fabrizio Quarantelli, Timothy P. Hughes, Deborah L. White, Dong-Wook Kim, MD, Harriet Goh, Jerald P. Radich, MD, Lan Beppu, Giuseppe Saglio, MD, PhD, Daniela Cilloni, Ilaria Iacobucci, Giovanni Perini, Giorgio Cantelli Forti, Gianantonio Rosti, Alan Hatfield, MD, Michele Baccarani, MD, Patrizia Hrelia, Giovanni Martinelli
Journal: Blood
Blood (2010) 116 (21): 670.
https://doi.org/10.1182/blood.V116.21.670.670
Published: 2010
Journal Articles

Association Between Imatinib (IM) Transporters and Metabolizing Enzymes Genotype and Response in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients (Pts) Is Influenced by Ethnicity.

Simona Soverini, PhD, Sabrina Angelini, Eleonora Turrini, Fabrizio Pane, MD, Fabrizio Quarantelli, Timothy P. Hughes, MD, MBBS, Deborah L White, PhD, Dong Wook Kim, Harriet Goh, Jerald Radich, Lan Beppu, Giuseppe Saglio, Daniela Cilloni, MD, Carolina Terragna, Sandra Durante, Ilaria Iacobucci, PhD, Giovanni Perini, Ph.D., Patrizia Hrelia, Giorgio Cantelli Forti, Thea Kalebic, MD, Matt Barnett, Mark Thornquist, Michele Baccarani, MD, Giovanni Martinelli
Journal: Blood
Blood (2009) 114 (22): 3283.
https://doi.org/10.1182/blood.V114.22.3283.3283
Published: 2009
Journal Articles

Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph+ Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients.

Nicola Esposito, PhD, Concetta Quintarelli, PhD, Irene Colavita, PhD, Barbara Izzo, PhD, Anna Lucia Peluso, PhD, Margherita Ruoppolo, PhD, Luigi Del Vecchio, MD, Domenico Russo, Susan Branford, PhD, Ilaria Iacobucci, PhD, Mark Thornquist, Matt Barnett, Junia Melo, Giuseppe Saglio, Jerald Radich, Lin Peter, Giovanni Martinelli, Thea Kalebic, MD, Timothy Hughes, Fabrizio Pane
Journal: Blood
Blood (2009) 114 (22): 2212.
https://doi.org/10.1182/blood.V114.22.2212.2212
Published: 2009
Journal Articles

The Expression of shp-1 and SHP-2: A Novel Powerful Predictor of Major Molecular Response (MMR) Achievement in Chronic Myeloid Leukemia Gleevec-Treated Patients Enrolled into the TOPS Clinical Trial.

Nicola Esposito, PhD, Fabrizio Quarantelli, Luigia Luciano, MD, Barbara Izzo, PhD, Anna Lucia Peluso, PhD, Marco Picardi, MD, Susan Branford, PhD, D.L. White, PhD, Timothy Hughes, PhD, Jerald Radich, Simona Soverini, PhD, Ilaria Iacobucci, PhD, Giuseppe Saglio, MD, Thea Kalebic, PhD, Mark Thornquist, PhD, Giovanni Martinelli, MD, Fabrizio Pane, MD
Journal: Blood
Blood (2008) 112 (11): 1106.
https://doi.org/10.1182/blood.V112.11.1106.1106
Published: 2008
Journal Articles

CML Patients with Low OCT-1 Activity Achieve Better Molecular Responses on High Dose Imatinib Than on Standard Dose. Those with High OCT-1 Activity Have Excellent Responses on Either Dose: A TOPS Correlative Study

Deborah L White, PhD, Verity A Saunders, Phuong Dang, Amity Frede, Laura Eadie, Simona Soverini, PhD, Fabrizio Quarantelli, Peter Lin, Mark Thornquist, Dong-Wook Kim, MD, PhD, Fabrizio Pane, MD, Giovanni Martinelli, Jerald Radich, Thea Kalebic, MD, Giuseppe Saglio, MD, Timothy Hughes, MD
Journal: Blood
Blood (2008) 112 (11): 3187.
https://doi.org/10.1182/blood.V112.11.3187.3187
Published: 2008